Affimed N.V.
AFMD · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $8,275 | $41,353 | $40,366 | $28,360 |
| % Growth | -80% | 2.4% | 42.3% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $8,275 | $41,353 | $40,366 | $28,360 |
| % Margin | 100% | 100% | 100% | 100% |
| R&D Expenses | $94,958 | $98,814 | $81,488 | $49,989 |
| G&A Expenses | $24,675 | $32,075 | $24,218 | $13,715 |
| SG&A Expenses | $24,675 | $32,075 | $24,218 | $13,715 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$4,697 | $0 | $0 | $626 |
| Operating Expenses | $114,936 | $130,889 | $105,706 | $63,704 |
| Operating Income | -$106,661 | -$88,119 | -$64,030 | -$34,718 |
| % Margin | -1,289% | -213.1% | -158.6% | -122.4% |
| Other Income/Exp. Net | $726 | $2,117 | $6,509 | -$6,647 |
| Pre-Tax Income | -$105,935 | -$86,002 | -$57,521 | -$41,365 |
| Tax Expense | $3 | $2 | $2 | $1 |
| Net Income | -$105,938 | -$86,004 | -$57,523 | -$41,366 |
| % Margin | -1,280.2% | -208% | -142.5% | -145.9% |
| EPS | -7.09 | -6.04 | -4.81 | -4.96 |
| % Growth | -17.4% | -25.6% | 3% | – |
| EPS Diluted | -7.09 | -6.04 | -4.81 | -4.96 |
| Weighted Avg Shares Out | 14,940 | 14,236 | 11,950 | 8,347 |
| Weighted Avg Shares Out Dil | 14,940 | 14,236 | 11,950 | 8,347 |
| Supplemental Information | – | – | – | – |
| Interest Income | $509 | $361 | -$415 | $186 |
| Interest Expense | $1,806 | $1,630 | $712 | $95 |
| Depreciation & Amortization | $1,749 | $2,847 | $1,387 | $1,039 |
| EBITDA | -$102,380 | -$81,473 | -$55,422 | -$40,231 |
| % Margin | -1,237.2% | -197% | -137.3% | -141.9% |